1. Cardiovascular Autonomic Dysfunction in Patients with Cancer

   • Ben G. T. Coumbe
   • John D. Groarke

   Cardio-Oncology (SA Francis and RB Morgan, Section Editors) 03 July 2018 Article: 69

   

2. Long-term Management of the Arterial Switch Patient

   • Jared Kirzner
   • Altaf Pirmohamed
   • Harsimran S. Singh

   Congenital Heart Disease (RA Krasuski, Section Editor) 26 June 2018 Article: 68

   

3. Update on Incorporating Biomarkers with Imaging Findings for the Detection and Management of Cardiotoxicity

   • Neha Quatromoni
   • Marielle Scherrer-Crosbie

   Cardio-Oncology (SA Francis and RB Morgan, Section Editors) 22 June 2018 Article: 67

4. HDL Mimetics Infusion and Regression of Atherosclerosis: Is It Still Considered a Valid Therapeutic Option?

   • I. Karalis
   • J. W. Jukema

   Lipid Abnormalities and Cardiovascular Prevention (G De Backer, Section Editor) Open access 21 June 2018 Article: 66

   

5. Cardiovascular and Renal Outcomes of Newer Anti-Diabetic Medications in High-Risk Patients

   • Lima Lawrence
   • Venu Menon
   • Sangeeta Kashyap

   Ischemic Heart Disease (D Mukherjee, Section Editor) 21 June 2018 Article: 65

   

6. Gender Disparities in Presentation, Management, and Outcomes of Acute Myocardial Infarction

   • Matthew Liakos
   • Puja B. Parikh

   Ischemic Heart Disease (D Mukherjee, Section Editor) 16 June 2018 Article: 64

7. Cardiomyocyte Proliferation for Therapeutic Regeneration

   • John P. Leach
   • James F. Martin

   Regenerative Medicine (SM Wu, Section Editor) 14 June 2018 Article: 63

   

8. Colchicine in Pericardial Disease: from the Underlying Biology and Clinical Benefits to the Drug-Drug Interactions in Cardiovascular Medicine

   • Aldo L. Schenone
   • Venu Menon

   Pericardial Disease (AL Klein, Section Editor) 14 June 2018 Article: 62

9. Use of Interleukin-1 Blockers in Pericardial and Cardiovascular Diseases

   • Giacomo Emmi
   • Maria Letizia Urban
   • Antonio Brucato

   Pericardial Disease (AL Klein, Section Editor) 14 June 2018 Article: 61

   

10. Determinants of Achieved LDL Cholesterol and “Non-HDL” Cholesterol in the Management of Dyslipidemias

    • Chris J. Packard

    Lipid Abnormalities and Cardiovascular Prevention (G De Backer, Section Editor) 14 June 2018 Article: 60